Pharmagen, Inc.

Equities

PHRX

US71715W1062

Delayed OTC Markets Other stock markets 12:46:06 14/06/2024 am IST			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

2015	Pharmagen, Inc. cancelled the transaction announced on November 30, 2012	CI
2014	Pharmagen, Inc. Announces Management Changes	CI

Pharmagen, Inc. Announces Executive Changes

June 11, 2014 at 10:54 pm IST

Pharmagen, Inc. announced that effective June 10, 2014, Mackie Barch, President and Chief Executive Officer, resigned those positions and was appointed as Founder and Vice-Chairman of the board of directors.

Latest news about Pharmagen, Inc.

Pharmagen, Inc. cancelled the transaction announced on November 30, 2012	30/15/30	CI
Pharmagen, Inc. Announces Management Changes	03/14/03	CI
Pharmagen, Inc. Announces Executive Changes	11/14/11	CI
Pharmagen, Inc. Appoints Russell Skibsted as Executive Vice President and Chief Financial Officer	11/14/11	CI
Pharmagen Appoints Additional Members to its Board of Directors	29/14/29	CI
Pharmagen Recruits Frederick W. Mundt as Senior Vice President of Sales	06/14/06	CI
Pharmagen, Inc. Appoints Boyd Relac as Chief Operating Officer	29/14/29	CI
Pharmagen, Inc. announced that it has received $0.5 million in funding	01/14/01	CI
Pharmagen, Inc. Appoints Richard A. Wolpow as Member of Board of Directors and Interim-Chief Operating Officer	24/14/24	CI
Pharmagen, Inc. announced that it has received $0.15 million in funding.	24/14/24	CI
Pharmagen, Inc. Appoints Richard A. Wolpow as Chairman of the Board of Directors and Interim Chief Operating Officer	17/13/17	CI
Pharmagen, Inc. announced that it expects to receive $0.5 million in funding	12/13/12	CI
Pharmagen, Inc. Announces Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2013	15/13/15	CI
Pharmagen Seeks Acquisitions	31/13/31	CI
Pharmagen, Inc. announced that it has received $0.04 million in funding from Asher Enterprises, Inc.	09/13/09	CI
Pharmagen, Inc. announced that it expects to receive $0.04 million in funding from Asher Enterprises, Inc.	01/13/01	CI
Pharmagen, Inc. announced that it has received $0.06 million in funding from Asher Enterprises, Inc.	19/13/19	CI
Pharmagen, Inc. announced that it expects to receive $0.06 million in funding from Asher Enterprises, Inc.	05/13/05	CI
Pharmagen, Inc. Announces Earnings Results for the First Quarter Ended March 31, 2013	15/13/15	CI
Pharmagen, Inc. Announces Consolidated Earnings Results for the Fiscal Year Ended December 31, 2012	01/13/01	CI
Pharmagen, Inc. announced that it has received $0.60 million in funding from Trafalgar Capital Advisors LTD.	29/13/29	CI
Pharmagen, Inc. announced that it expects to receive $2 million in funding from Trafalgar Capital Advisors LTD.	28/13/28	CI
Sunpeaks Ventures, Inc. will Change its Ticker to PHRX from SNPK	15/13/15	CI
Sunpeaks Ventures, Inc. Creates New Operating Unit, Pharmagen Nutraceuticals	14/13/14	CI
Sunpeaks Ventures, Inc. has Changed its Name to Pharmagen, Inc	14/13/14	CI

Chart Pharmagen, Inc.

Duration

Period

More charts

Company Profile

Sector

More about the company